Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 34.30% | -0.46% | 316.00% | -178.26% | -35.26% |
| Total Depreciation and Amortization | -2.19% | 1.52% | 244.12% | -161.26% | 1.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.75% | 125.57% | -88.23% | 1,847.77% | -66.10% |
| Change in Net Operating Assets | -322.40% | 104.32% | -298.65% | 272.71% | -202.41% |
| Cash from Operations | 5.16% | 198.75% | -71.91% | 138.82% | -51.25% |
| Capital Expenditure | -53.45% | -10.40% | -9.67% | 51.69% | -48.41% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 601.67% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -70.87% | 271.04% | -- |
| Cash from Investing | 1.76% | -1,078.68% | 49.01% | 104.58% | -76.33% |
| Total Debt Issued | -- | -- | -- | 73.68% | -- |
| Total Debt Repaid | -50.00% | 13.04% | 8.00% | -525.00% | -- |
| Issuance of Common Stock | 532.18% | -79.83% | 277.37% | -58.14% | 168.45% |
| Repurchase of Common Stock | 87.49% | 86.44% | 90.77% | 0.05% | -30.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.38% | -0.21% | -0.46% | 1.53% | 1.22% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.80% | -10.82% | 51.13% | -32.93% | 18.84% |
| Foreign Exchange rate Adjustments | -387.65% | 134.13% | -109.06% | 1,335.99% | 80.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.32% | 262.08% | -180.05% | 158.34% | -269.12% |